John Yu
Chief Executive Officer at Kairos Pharma Ltd.
Profile
John S.
Yu was the founder of ImmunoCellular Therapeutics Ltd.
(founded in 1987) and Kairos Pharma Ltd.
(founded in 2013), where he held the titles of Chairman, Secretary & Chief Scientific Officer and Chairman & Chief Executive Officer, respectively.
He is currently the Director-Surgical Neuro Oncology at Cedars-Sinai Medical Center, a position he has held since 1998.
Dr. Yu's education includes a graduate degree from Harvard University in 1990, an undergraduate degree from Stanford University in 1985, and a doctorate degree from Harvard Medical School in 1990.
John Yu active positions
| Companies | Position | Start |
|---|---|---|
Kairos Pharma Ltd.
 Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA. | Chief Executive Officer | 16/06/2013 |
Cedars-Sinai Medical Center
 Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 31/12/1997 |
Former positions of John Yu
| Companies | Position | End |
|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Founder | - |
Training of John Yu
| Harvard University | Graduate Degree |
| Stanford University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |
Kairos Pharma Ltd.
Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA. | Health Technology |
- Stock Market
- Insiders
- John Yu
